Chemoinformaics analysis of 7BETA,12ALPHA-DIHYDROXYKAURENOLIDE
Molecular Weight | 332.44 | nRot | 0 |
Heavy Atom Molecular Weight | 304.216 | nRig | 24 |
Exact Molecular Weight | 332.199 | nRing | 5 |
Solubility: LogS | -4.102 | nHRing | 1 |
Solubility: LogP | 2.587 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 20 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 55.2782 |
nHD | 2 | BPOL | 30.6938 |
QED | 0.528 |
Synth | 6.278 |
Natural Product Likeliness | 3.849 |
NR-PPAR-gamma | 0.055 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.008 |
HIA | 0.096 |
CACO-2 | -5.004 |
MDCK | 0.0000271 |
BBB | 0.936 |
PPB | 0.583266 |
VDSS | 0.645 |
FU | 0.495663 |
CYP1A2-inh | 0.014 |
CYP1A2-sub | 0.365 |
CYP2c19-inh | 0.018 |
CYP2c19-sub | 0.823 |
CYP2c9-inh | 0.026 |
CYP2c9-sub | 0.195 |
CYP2d6-inh | 0.016 |
CYP2d6-sub | 0.315 |
CYP3a4-inh | 0.556 |
CYP3a4-sub | 0.254 |
CL | 15.706 |
T12 | 0.077 |
hERG | 0.016 |
Ames | 0.034 |
ROA | 0.699 |
SkinSen | 0.028 |
Carcinogencity | 0.106 |
EI | 0.02 |
Respiratory | 0.849 |
NR-Aromatase | 0.426 |
Antiviral | No |
Prediction | 0.5621 |